T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive
Clinical trial NCT02153905 · TERMINATED
Trial details
- NCT number
- NCT02153905
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-03
- Primary completion
- 2018-09-10
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.